Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-103-7 | CAS number: 629-70-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
No toxicity reported following oral or dermal administration of the test item (LD50 oral 40.0 mL/kg using a preparation declared to contain 90 % of test item; LD50 dermal > 5000 mg/kg).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 February 1973 to 27 February 1973
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards, well documented and acceptable for assessment.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- not applicable
- Principles of method if other than guideline:
- Preparation containing 90 % test item administered to albino rats (five groups of two animals) with 14 day observation period.
- GLP compliance:
- no
- Remarks:
- investigation took place before the introduction of GLP
- Test type:
- other: similar to acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Sherman-Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Five groups of albino rats (one male and one female per group) were set aside and observed for a period of one week to assure normalcy.
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- - Animals were starved for 24 hours.
- Doses were determined for each animal and administered directly into the stomach by means of a stomach tube.
- Animals were allowed food and water ad libitum during a fourteen day observation period. - Doses:
- 2.5, 5.0, 10.0, 20.0 and 40.0 mL/kg
- No. of animals per sex per dose:
- One male and one female per dose group
- Control animals:
- no
- Sex:
- male/female
- Dose descriptor:
- other: no toxicity reported following oral administration
- Mortality:
- No mortality
- Clinical signs:
- other: Not reported
- Gross pathology:
- Not reported
- Other findings:
- Not reported
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test material was demonstrated to have an acute oral oral LD50 greater than 40.0 mL/kg in the rat.
- Executive summary:
METHOD
A preparation declared to contain 90 % of test item was administered in a single dose by gavage to five groups of Sherman-Wistar rats consisting of one male and one female. Mortality after a fourteen day observation period was reported.
RESULTS
No mortality was observed in rats dosed with 2.5, 5.0, 10.0, 20.0 or 40.0 mL/kg of the test material.
CONCLUSION
The test material was demonstrated to have an acute oral LD50 greater than 40.0 mL/kg in the rat.
Reference
Dose Level mL/kg |
Number of rats dosed |
Day |
Mortality after 14 days |
|||||||||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
|||
2.5 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/2 |
5.0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/2 |
10.0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/2 |
20.0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/2 |
40.0 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/2 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Oral
A preparation declared to contain 90 % of test item was administered in a single dose by gavage to five groups of Sherman-Wistar rats consisting of one male and one female. Mortality after a fourteen day observation period was reported.
No mortality was observed in rats dosed with 2.5, 5.0, 10.0, 20.0 or 40.0 mL/kg of the test material and the acute oral LD50 was determined to be 40.0 mL/kg in the rat.
Inhalation
According to REACH Annex XIII Section 8.5 information on acute toxicity will be provided for at least one other route in addition to the oral route. The choice for the second route will depend on the nature of the substance and the likely route of human exposure. The substance is a waxy solid with a vapour pressure of 4.8E-03 Pa at 25°C and is used exclusively as a cosmetic ingredient. Based on evaluation of the life cycle of the substance it is concluded that inhalation exposure will be low and that the most likely route of exposure for workers and consumers is the dermal route. Testing for acute toxicity via the inhalation route is, therefore, not required.
Dermal
The final report of the Cosmetic Ingredient Review Expert Panel on the safety assessment of methyl acetate (Heldreth et al, International Journal of Toxicology, Vol 31, No 4, Suppl 07.2012) cites an unpublished report submitted to the Research Institute for Fragrance Materials Inc by Moreno in 1980 and accepts the quoted dermal LD50 of > 5000 mg/kg in rats and rabbits as evidence that the test item does not cause systemic toxicity via the dermal route. This conclusion is underpinned by a study (see Section 7.10.5) in which 50 % test material in petrolatum (equivalent to 45 % of the test item described in this dossier) did not elicit any response in 50 out of 53 human volunteers when applied to the same test site for 24 hours on four consecutive days for a period of three weeks. Furthermore, the test item is used exclusively as a cosmetic ingredient for which animal testing is discouraged, and it is handled at industrial sites where stringent risk mitigation measures are routinely incorporated into operational procedures.As a result, and in line with the ECHA news alert ‘Clarity on interface between REACH and the Cosmetics Regulation’ of 27 October 2014, where registrants are permitted to perform animal testing to meet the human health information requirements of REACH only when there is a need to assess worker safety, it is considered inappropriate to carry out further investigations involving vertebrate animals.
Justification for selection of acute toxicity – oral endpoint
Meets generally accepted scientific standards, well documented and acceptable for assessment.
Justification for classification or non-classification
No adverse effect has been reported during investigation of acute toxicity via the oral route in the rat and via the dermal route in rats and rabbits. As such, classification in accordance with Regulation (EC) No 1272/2008 is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.